Cumberland Pharmaceuticals Inc.
CPIX
$3.40
$0.144.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.09M | 15.11M | 17.96M | 17.46M | 17.34M |
| Total Receivables | 10.32M | 10.49M | 11.70M | 11.31M | 11.62M |
| Inventory | 3.22M | 4.10M | 4.00M | 4.51M | 4.30M |
| Prepaid Expenses | 1.58M | 2.18M | 2.79M | 1.95M | 2.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 31.21M | 31.88M | 36.45M | 35.24M | 35.58M |
|
|
|||||
| Total Current Assets | 31.21M | 31.88M | 36.45M | 35.24M | 35.58M |
| Net Property, Plant & Equipment | 7.42M | 7.48M | 6.45M | 6.52M | 6.70M |
| Long-term Investments | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Goodwill | 914.00K | 914.00K | 914.00K | 914.00K | 914.00K |
| Total Other Intangibles | 15.99M | 16.99M | 17.97M | 19.42M | 20.46M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.38M | 12.68M | 13.79M | 14.66M | 14.86M |
| Total Assets | 67.91M | 69.94M | 75.58M | 76.75M | 78.52M |
|
|
|||||
| Total Accounts Payable | 13.45M | 13.93M | 13.91M | 12.06M | 12.51M |
| Total Accrued Expenses | -- | -- | 9.74M | -- | -- |
| Short-term Debt | -- | -- | 5.10M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 386.10K | 371.10K | 356.50K | 6.38M | 376.80K |
| Total Finance Division Other Current Liabilities | 10.14M | 11.22M | 2.51M | 12.65M | 11.87M |
| Total Other Current Liabilities | 10.14M | 11.22M | 2.51M | 12.65M | 11.87M |
| Total Current Liabilities | 23.97M | 25.52M | 31.62M | 31.09M | 24.76M |
|
|
|||||
| Total Current Liabilities | 23.97M | 25.52M | 31.62M | 31.09M | 24.76M |
| Long-Term Debt | 5.24M | 5.24M | 10.18M | 10.10M | 16.09M |
| Short-term Debt | -- | -- | 5.10M | -- | -- |
| Capital Leases | 4.71M | 4.83M | 4.94M | 5.00M | 5.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.30M | 6.01M | 6.30M | 6.09M | 6.54M |
| Total Liabilities | 40.23M | 41.60M | 53.04M | 52.28M | 52.49M |
|
|
|||||
| Common Stock & APIC | 51.44M | 51.37M | 46.82M | 46.84M | 46.87M |
| Retained Earnings | -23.45M | -22.71M | -23.97M | -22.06M | -20.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 27.99M | 28.66M | 22.85M | 24.78M | 26.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.99M | 28.66M | 22.85M | 24.78M | 26.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -310.90K | -316.40K | -307.50K | -309.70K | -316.80K |
| Total Equity | 27.68M | 28.34M | 22.55M | 24.47M | 26.03M |
|
|
|||||